Abstract
The endogenous timekeeping system evolved to anticipate the time of the day through the 24 hours cycle of the Earthās rotation. In mammals, the circadian clock governs rhythmic physiological and behavioral processes, including the daily oscillation in glucose metabolism, food intake, energy expenditure, and whole-body insulin sensitivity. The results from a series of studies have demonstrated that environmental or genetic alterations of the circadian cycle in humans and rodents are strongly associated with metabolic diseases such as obesity and type 2 diabetes. Emerging evidence suggests that astrocyte clocks have a crucial role in regulating molecular, physiological, and behavioral circadian rhythms such as glucose metabolism and insulin sensitivity. Given the concurrent high prevalence of type 2 diabetes and circadian disruption, understanding the mechanisms underlying glucose homeostasis regulation by the circadian clock and its dysregulation may improve glycemic control. In this review, we summarize the current knowledge on the tight interconnection between the timekeeping system, glucose homeostasis, and insulin sensitivity. We focus specifically on the involvement of astrocyte clocks, at the organism, cellular, and molecular levels, in the regulation of glucose metabolism.
Functional Hierarchy Of the Timekeeping System
The circadian (in Latin ācircaā, around; ādiemā, day) clock is an endogenous and selfāsustaining oscillator that operates with a periodicity of 24āhours (h) to maintain proper rhythms of the vast majority of physiological and behavioral processes, including food intake, energy balance, sleep-wake cycles and many others (). In mammals, the timekeeping system comprises a pacemaker located in the hypothalamic suprachiasmatic nucleus (SCN) (, ), as well as non-SCN brain and peripheral clocks and cell-autonomous oscillators within virtually every cell type of the body (, ). In the absence of any time cue from the environment, these clocks free run with a period close to 24Ā h. To compensate discrepancies between this intrinsic period and the environmental cycle, circadian clocks entrain to external Zeitgebers (ZT, in German ātime giverā). The light entrains the SCN to local time which in turn, conveys the temporal information to other clocks in the brain and peripheral tissues via neuronal, hormonal, or behavioral activity rhythms, such as the feeding-fasting and sleep-wake cycles, which serve as entrainment signals for extra-SCN clocks (6, ) (Figure 1).
Figure 1
While a substantial amount of information is known about the neuroanatomy of the SCN, the mechanisms of light-affected entrainment and the transmission of time cues to other brain areas or peripheral clocks are not yet fully understood. Briefly, the SCN is a heterogeneous and complex bilateral nucleus (, ) comprising approximately 10,000 self-oscillating neurons on each side, in mice (ā). Each part is divided into two functional subgroups, one in the ventrolateral region and the other in the dorsal SCN. The ventrolateral region or core receives direct photic inputs from the intrinsically photosensitive retinal ganglion cells (ipRGCs) (ā). Activation of the retino hypothalamic tract by light increases the firing of vasoactive intestinal polypeptide (VIP)-expressing SCN cells and VIP release. VIP neurons set and phase-shift the circadian time by VIPergic and Ī³-aminobutyric acid (GABA)ergic signaling to arginine vasopressin (AVP)-expressing neurons within the second subgroup of cells located in the dorsal SCN or shell (Figure 1). Ultimately, this results in the induction of the so-called clock genes Period1 (Per1) and Period2 (Per2) () and subsequent time-of-day dependent phase responses of the SCN, thereby enabling entrainment to the light-dark (LD) cycle.
If food availability is restricted to a particular time of day or night (often referred to as time-restricted feeding, TRF), animals exhibit increased activity in anticipation of feeding (termed food anticipatory activity, FAA). Moreover, in this paradigm, the peripheral clocks shift their phase to preserve alignment with mealtime. The effects of TRF on peripheral clocks and/or behavior persist even when the feeding is out of phase with the LD cycle, and, indeed, can be uncoupled from the SCN, which remains synchronized to the light (ā). Remarkably, in the absence of a functional SCN, FAA is preserved and food intake becomes an effective ZT capable of coordinating circadian rhythms of behavior, peripheral clock gene expression, and clock outputs, such as hormone secretion (, ). Thereby, the entrainment to TRF has been proposed to be independent of the SCN and driven by a food-entrainable oscillator (FEO) of still unknown location. A recent study reported that innervation of ipRGC to neuropeptide Y (NPY)-expressing intergeniculate leaflet (IGL) neurons in early postnatal stages, allow the entrainment to TRF in adults. In this model, TRF inhibitory signals from IGLNPY neurons modulate the SCN activity, allowing the FEO signals to influence FAA ().
As hypothalamic lesions and gene knockouts (KOs) targeting specific cell types in the hypothalamus, brainstem, or forebrain areas also impair FAA (ā), it is reasonable to hypothesize that the FEO might be functionally distributed among brain areas that are competent to drive changes in behavior instead to be restricted to a particular brain region. In line with this idea, it was recently reported that the action of insulin (INS) and insulin-like growth factor-1 (IGF-1) triggered after feeding, on different brain regions, are necessary and sufficient for both the FAA and the phase-shift of body clocks (). Remarkably, an elegant study showed that the signal that generates FAA might be synthesized in the liver. Specifically, it was shown that liver PER2 is required for hepatic-derived ketone bodies production which in turn signals the brain to induce FAA (). In sum, the FEO may not be in a single tissue but it might be of systemic nature. In this context, the feeding-related signals, such as INS and ketones generated in peripheral tissues, entrain different brain regions competent to drive changes in behavior. Among these regions is included the SCN, which is tuned by innervation of ipRGCs to IGL during development to allow non-photic entrainment to food () (Figure 1).
Astrocyte Circadian Clocks
How the activity of a small number of SCN neurons is translated into rhythmic behaviors or physiology at the organism level? The human brain contains more than 100 billion cells, the majority being glial cells, coordinated by this endogenous clock to determine alertness waxes and wanes in a highly predictable manner over the course of a 24Ā h day (). However, how this clock signaling is orchestrated within so many brain cells that lead to the cycle-to-cycle precision of circadian rhythmicity is unknown. Consequently, we face a lack of knowledge on the mechanisms by which circadian dysfunction affects a wide range of physiological processes such as metabolic imbalance, premature aging, and reduced longevity (ā38).
Astrocytes have long lived in the shadow of the neurons as they were thought to have mainly a structural role in the central nervous system. The recent findings showing the critical role of the astrocyte clock in the control of SCN function and circadian behavior (39ā43) is a game-changing discovery that offers radically new research directions for therapy of brain diseases originated by environmental miss functioning of circadian rhythms or genetic factors affecting clock genes or outputs. This glial cell type is highly diverse in its morphological appearance, functional properties, and distribution among and within different brain regions (44, 45). However, they share three anatomical features that are crucial to understand its functional contributions to the timekeeping system.
Firstly, the longstanding concept that astrocytic processes interdigitate to create a scaffold for the neuronal organization, has been challenged by several studies showing that, in vivo, astrocytes are organized in nonoverlapping domains, i.e, with little interaction between adjacent cells (46ā48). Thus, one astrocyte can coordinate the activity of multiple sets of contiguous synapses, via regulation of neurotransmitters levels in the synaptic cleft, via control of the extracellular space, or by releasing chemical signals that actively modulate synaptic transmission, often referred to as gliotransmitters. Specifically, astrocytes play an essential role in the coupling of SCN neurons by controlling both glutamate and GABA levels (40, 42, 43, 49ā51). Moreover, SCN astrocytes undergo rhythmic structural rearrangements (52), along with rhythms in GFAP expression (53), which allows differential day/night coverage of VIP neurons to facilitate entrainment to light (52, 54). Similarly, in response to metabolic cues, astrocytes undergo structural and morphological changes to influence the synaptic inputs within the hypothalamic melanocortin system, which might ultimately affect the feeding behavior (55ā58). Astrocytes also regulate the extracellular space (59ā62), enabling the exchange of solutes between the cerebrospinal fluid and the interstitial space, a system referred to as glymphatic clearance. As the diffusion of SCN output signals is sufficient for rhythmic behavior (63, 64), daily changes in the glymphatic system may underly the synchronization among different brain regions across the circadian cycle. On the other hand, in Drosophila, a glial-released factor was shown to be critical for normal rhythmicity by regulating a neurotransmitter, pigment dispersing factor, acting on a receptor similar to that for VIP in mammals (65ā67). Similarly, in rodents, astrocytes release gliotransmitters, such as ATP, in a circadian manner (68), and arrhythmic astrocytes alter VIP expression in vivo (40). However, whether ATP release and/or astrocytic rhythmic metabolism impact the activity patterns of VIP neurons is still unknown.
Secondly, astrocytes form a syncytium, via gap junctions, that allow the propagation of small signaling molecules through the glial network (69). Pharmacological inhibition of gap junctions in SCN slides (70, 71) and mouse models with deletion of the neuronal connexin-36, impairs the circadian pattern of neuronal activity without affecting the long-term synchronization of clock gene expression (72) and with mild effect on behavioral rhythms (73). Similarly, studies in mouse models with deletion of astrocytic specific connexins indicate that the astrocytic coupling in the SCN is dispensable for circadian rhythm generation and light-entrainment (74). However, recently, a long-range function of astrocytes for the transmission of timing cues to distant neural populations was investigatedĀ in vitroĀ with microfluidic devices that allowed compartmentalizing distinct neuronal populations connected through a network of astrocytes. In this paradigm, astrocytes were able to synchronize the clock of segregated cortical neuronal populations if intercellular communication between the glial network and/or calcium signaling were intact (75). Whether astrocytes are involved in the spatial transmission of timing cues in other extra-SCN brain regions in vivo is still unknown.
Thirdly, the exchange of metabolites and hormones through the blood-brain barrier (BBB) relies on astrocytes and is dependent both on the sleep/wake state and in the circadian clock (59, 76ā80). As hypothalamic astrocytes have a crucial role in sensing nutrients such as glucose and fatty acids (56, 81ā83) and express receptors for leptin (84, 85), IGF-1 (86), thyroid hormone (87), INS (57), and glucocorticoids (GCs) (88, 89) among others, they could link or coordinate peripheral and central oscillators. For example, astrocytes, as wellāknown targets of GCs, might be sensitive to the negative feedback loop of the hypothalamusāpituitaryāadrenal axis. It is widely accepted that GC signaling can reset peripheral clocks but not the central pacemaker because SCN neurons do not express the GC receptor (90). However, astrocytic feedback loops, via GC signaling, could explain the so far puzzling results showing that the Per1āLuc phases of SCN were affected significantly when adrenalectomized animals were treated with hydrocortisone (6).
Molecular Dynamics of the Clock
The Nobel Prize in Physiology or Medicine in 2017 was awarded to three Chronobiologists who first cloned the Droshopila Period gene in 1984 (91, 92). This finding allowed us to understand how the timekeeping system anticipates the environmental changes related to the Earthās rotation in most, if not all, living organisms.
The molecular clock involves rhythmic and selfāsustained transcriptionalātranslational feedback loops (TTFLs) of clock genes/proteins (Figure 2). The Eābox specific transcription factors BMAL1 (Brain and muscle Arntālike proteinā1) and CLOCK (Circadian locomotor output cycles kaput) are the positive limb of the TTFL, which heterodimerize to activate transcription of the repressors Per1/2/3 and Cryptochrome genes (Cry1/2) (93, 94). The negative loop comprises PER/CRY heterocomplex that, upon accumulation, lead to the degradation of BMAL1/CLOCK dimers, thus inhibiting their own transcription (95). Hence, a new cycle of PER and CRY protein accumulation begins, generating rhythmic changes in the levels of the core clock transcripts and proteins that persist for approximately 24Ā h (96) (Figure 2). In a secondary feedback loop, the CLOCK- BMAL1 complex controls the rhythmic expression of the genes encoding the REV-ERB nuclear hormone receptors and ROR (97). In turn, REV-ERB and ROR compete for the same RORE elements within the Clock and Bmal1 promoter, repressing or activating, respectively, Clock and Bmal1 transcription (Figure 2).
Figure 2
Direct targets of CLOCK/BMAL1, referred to as clock-controlled genes (CCGs), include genes that are critically involved in rhythmic processes such as feeding behavior, sleep-wake cycle, and glucose homeostasis (, 98) (Figure 2). In turn, metabolic state sensing pathways also alter the molecular clock in anticipation of the LD cycle. Specifically, during feeding, anabolic processes are triggered by the activation of the INS-AKT-mTOR pathway, whereas during fasting, AMP-activated protein kinase (AMPK) activation triggers catabolic processes and inhibits mTOR activity (99). BMAL1 phosphorylation and PER2 translation are regulated by the INS-AKT-mTOR pathway that is activated in the postprandial state (, 100ā102). Similarly, in peripheral tissues, AMPK1, which senses cellular ATP levels, modulate CRY1 phosphorylation and thus its rhythmic degradation (103). Additionally, high levels of glucose control the period length via O- GlcNAcylation of CLOCK, BMAL1, and PER2 (104ā106). The molecular clocks are also sensitive to the ratio of reduced to oxidized nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD), which are indirect sensors of cellular energy status. Oxidation of NAD is under control of the clock and, in turn, prevents the deacetylation and this the transcriptional activity of CLOCK-BMAL1 complex by Sirtuin 1 (SIRT1) and poly-ADP-ribosylation mediated by poly(ADP-ribose) polymerase 1 (107ā110) (Figure 2).
In summary, the circadian system ensures a temporal partitioning of catabolic and anabolic reactions synchronizing organism metabolism to the feeding-fasting cycle. However, as the connection of metabolism and the circadian clock works in both directions (111) is not surprising that animal models of genetic clock defects display metabolic alterations and that clock alterations can be found in metabolically challenged conditions (112).
Coordination of Glucose Homeostasis by Central and Peripheral Clocks
Glucose homeostasis is optimal when fasting-feeding and rest-activity cycles, hormonal rhythms, and central and peripheral clocks oscillate in synchrony with each other to ensure that the timing cues and tissue responsiveness are achieved at the right time. During the active phase, metabolic tissues such as the liver, muscle, and fat are very sensitive to INS to guarantee that glucose uptake is properly achieved after food intake. Conversely, these tissues are more resistant to the hormone during the fasting phase, to facilitate the endogenous glucose production and free fatty acid (FFA) secretion (113ā115). In this section, we discuss the clocks in the tissues and organs involved in the control of glucose homeostasis and describe their role in the regulation of INS sensitivity and secretion.
The hypothalamus integrates glucose-sensing mechanisms with multiple effector pathways to precisely coordinate hepatic glucose production, muscle and fat glucose uptake, and endocrine pancreas function (Figure 3). Briefly, in the arcuate nucleus of the hypothalamus (ARC), orexigenic agouti-related peptide (AgRP)-producing neurons, and anorexigenic neurons releasing the pro-opiomelanocortin (POMC)-derived peptide, Ī±-melanocyte-stimulating hormone, together with the neurons expressing the melanocortin 4 receptor (MC4R), are essential for glucose sensing (117). AgRP neurons are glucose-inhibited cells whereas POMC neurons are glucose-excited (118). In general terms, competitive binding of Ī±-MSH and AgRP to MC4Rs defines the activation magnitude of downstream pathways and effectors. Furthermore, POMC and AgRP neurons project to numerous extrahypothalamic and hypothalamic regions, including the ventromedial nucleus (VMH) (119), which is crucial to initiate the glucose counter-regulatory response to hypoglycemia (120) (Figure 3). On the other hand, hypothalamic astrocytes respond to hyperglycemia by retraction of the coverage around POMC neurons to modify meal patterns (56). Consistently, astrocytes sense INS and leptin to coāregulate behavioral responses and metabolic processes via the control of brain glucose uptake and the glial ensheathment of POMC neurons, respectively (57, 58). Moreover, deletion of leptin receptors in astrocytes reduces the physiological anorexigenic response to this hormone and enhances fasting or ghrelin-induced hyperphagia (58). Additionally, stimulation of astrocytes with ghrelin modify glutamate and glucose metabolism as well as glycogen storage by decreasing GLUT2, glutamine synthetase, and lactate dehydrogenase, and increasing glutamate uptake, glycogen phosphorylase, and lactate transporters, which might modulate the signals/nutrients reaching neighboring neurons (121). Finally, activated astrocytes release adenosine to inhibit AgRP neurons, thus suppressing the ghrelin-mediated increase of food intake (122, 123) (Figure 3).
Figure 3
As the SCN imposes the sleep-wake cycle and food intake occurs in the active period, the involvement of the pacemaker in controlling glucose homeostasis and systemic INS sensitivity is indirect (124). Indeed, BMAL1 deletion in SCN does not affect the body weight despite complete loss of rhythmic behavior (). Moreover, the circadian locomotor activity but not the metabolic disturbances of Bmal1ā/ā mice were rescued by restoring BMAL1 expression in the SCN (125). Similarly, mice with astrocyteāspecific deletion of BMAL1 show altered energy balance and glucose homeostasis despite their circadian locomotor activity is not lost (39ā43). Thus, peripheral and/or extra-SCN hypothalamic clocks, but not the SCN, might have a crucial role in developing glucose intolerance and INS resistance. In line with this idea, BMAL1 ablation within SF1 neurons in the VMH is sufficient to alter energy expenditure (126). Additionally, AgRP-specific ablation of BMAL1 increases hepatic gluconeogenesis (127). However, currently, little is known about the specific physiological functions of extra SCN brain clocks. This knowledge could be highly valuable for biomedical understanding and future therapeutic advancement in the metabolic imbalance associated with circadian disruption.
Metabolic tissues involved in glucose homeostasis also have autonomous clocks that govern and adjust their daily metabolic function or outputs. For example, in the liver, with an essential role as a buffer for glucose variations arising from rhythmic food consumption, ablation of the local clock leads to hypoglycemia restricted to the fasting phase and exaggerated glucose clearance (128). Moreover, it was reported that while hepatic glycogenesis is controlled by CLOCK (129), gluconeogenesis in the fasted state, is under the regulation of the repressor CRY1 (130ā133). On the other hand, efficient glucose uptake by the hepatocytes at the beginning of the active phase depends on the rhythmic expression of glucose transporters and glucagon receptor (134, 135). Another tissue with a key role in the control of glucose homeostasis is the skeletal muscle. This tissue is responsible for 70-80% of INS-stimulated glucose uptake in the postprandial state (136). Interestingly, INS sensibility in muscle is controlled both by light and the local clock (137ā140). Specifically, it was shown that photic inputs entrain diurnal changes in clock gene expression and INS sensitivity in muscle via SIRT1 in SF1 neurons (140). On the other hand, deletion of the autonomous clock in muscle is sufficient to cause local INS resistance (137). Glucose uptake is also dependent on rhythmic INS action in the white adipose tissue (WAT) (141). However, contrary to liver or skeletal muscle, ablation of the local clock in WAT do not impact glucose homeostasis and INS sensitivity (142), suggesting that lipid mobilization is mainly regulated by the hypothalamic actions of INS and leptin. Finally, brown adipose tissue (BAT), which relays in FFA and glucose supply to regulate thermogenesis, is highly flexible in terms of glucose uptake potential and can significantly contribute to whole-body glucose metabolism under some conditions. In this tissue, INS-stimulated glucose uptake is regulated by the VMH and AgRP neurons (143ā145), as well as by the local clock (146, 147). Interestingly, mouse and human BAT express a red-light-sensitive protein, OPN3 (148), which increases glucose uptake upon red light stimulation. Recently, an elegant study demonstrated that animals reared without violet light show increased responses to Ī²-agonists, which in humans activate BAT, lower blood glucose levels, and increase and INS sensitivity. This effect was mediated by a violet light-sensing photoreceptor Opsin 5 (OPN5) in glutamatergic warm-sensing hypothalamic preoptic area neurons (149). Altogether, these studies open the possibility of modulating glucose homeostasis by manipulating environmental light.
Altogether this suggests that perturbed rhythms of the central and/or tissue clocks might lead to a mismatch between hepatic glucose production, muscle glucose uptake, and carbohydrate intake which could contribute to elevated levels of glucose and an imbalance between lipid storage in WAT and lipid oxidation in the brown adipose tissue. Furthermore, hyperglycemia in diabetes is traditionally attributed to reduced INS sensitivity in skeletal muscle and liver but also coupled to decreased INS secretion by the pancreas. Not only glucose homeostasis and INS sensitivity is under control of the local clocks in most of the above-mentioned metabolic tissues, but the pancreatic clock also controls rhythmic INS secretion (150, 151). Indeed, ablation of the pancreatic clock, in mice, is sufficient to cause hypoinsulinemia and hyperglycemia (150, 152ā154).
Interestingly, feeding-related hormones involved in the control of glucose homeostasis are timing cues for circadian behaviors. For example, leptin is involved in the regulation of sleep-wake cycles (155, 156); ghrelin, stimulate FAA in mice (157) and INS action, triggered after feeding, is a critical entrainment signal for the FEO (). Thus, an intriguing unsolved question concerns how the neurocircuits involved in glucose homeostasis and the central or peripheral clocks crosstalk and coordinate appropriate metabolic and/or circadian responses.
Integration of Glucose Homeostasis by Astrocyte Clocks and Cellular Metabolism
As brain metabolic pathways are compartmentalized between astrocytes and neurons, the coordination of both cell types is needed to meet the high energy requirements of synaptic transmission and correct brain function (158). Thereby, it is not surprising that hypothalamic glucose sensing requires an intact metabolic coupling between astrocytes and neurons (159). Interestingly, a big percentage of components of cellular metabolic pathways are direct targets of the molecular clock (96, 111, 160). Together, this suggests that the close association between altered glucose homeostasis and circadian disruption may arise from a shared defect in the astrocyte-neuron metabolic coupling. In turn, this might impact the neurocircuitry governing energy and glucose homeostasis or alter metabolic adaptations to hypoglycemia in the diabetic brain. In this section, we discuss the current evidence that supports this hypothesis.
The major energy source for the brain is glucose, which is taken up by astrocytes and neurons via glucose transporters (GLUTs) (161ā163). In the hypothalamus, the neuron-astrocyte glucose coupling expands beyond the accomplishment of energy requirements. For instance, astrocytes actively cooperate with hypothalamic neurons in detecting circulating glucose levels and in the generation of proper systemic metabolic responses (164). Not only astrocytic GLUT2 activity is involved in the regulation of systemic glucose homeostasis in rodents (165ā167), but restoring astrocytic GLUT2 reestablish the counterregulatory response to low-glucose in GLUT2 deficient mice (165). Remarkably, rhythmic GLUTs expression (137, 168, 169) is impaired in the brain of experimental streptozotocin-induced diabetes rats (169). Moreover, 24Ā h oscillation in glucose levels may modulate the expression of clock genes and transcriptional outputs within hypothalamic neurons involved in glucose homeostasis (170). Whether astrocyte-neuron metabolism in hypothalamic glucose sensing and associated-systemic response in the normal or diabetic brain relies on the astrocyte molecular clock remains to be investigated. However, this idea is reinforced by the recent finding that deletion ofĀ Bmal1Ā in astrocytes impairs INS sensitivity and glucose homeostasis (39).
Further, glucose can be stored as glycogen or metabolized in the glycolytic pathway to produce pyruvate, which is either transferred into mitochondria or converted to lactate. According to the āAstrocyte-to-Neuron Lactate Shuttleā (ANLS) hypothesis (171), lactate is primarily produced by astrocytes and transferred to neurons, where it is converted to pyruvate for aerobic energy production in mitochondria (Figure 3). Thereby, the production and the release of lactate by astrocytes is directly linked to neuronal activity, as showed in orexin neurons (172, 173). Consistent with the ANLS hypothesis, brain lactate levels increase during the awake state when neuronal firing rates are higher and vice versa, leading to a 24Ā h rhythm of lactate concentration (174, 175). In turn, astrocytic lactate release regulates the sleep-wake cycle (74) and entrain forebrain oscillators between states of alertness and tiredness by controlling the DNA binding of CLOCK/BMAL1 (176). Remarkably, during hypoglycemia in diabetes patients, brain lactate levels drop while its infusion increased brain lactate levels compared to healthy subjects (177ā179). These findings suggest increased lactate use as a metabolic substrate, impaired astrocyte lactate release, or perturbed compensatory metabolic mechanisms in the diabetic brain. Whether these effects underlie a potential astrocytic dysrhythmia is currently unknown.
More than half of the energy used by neurons during fasting derives from ketones bodies (180) synthesized by astrocytes. The astrocytic switch from glucose to FFA utilization (181, 182) to produce ketones is particularly enhanced in the hypothalamus (181), where stimulate neuropeptides critically involved in glucose sensing and energy homeostasis (83, 182, 183) (Figure 3). On the other hand, recurrent exposure to low glucose, mimicking variations often seen in patients with diabetes, results in increased astrocytic ketogenesis (184ā186), likely to preserve brain ATP production (187). In turn, increased astrocytic ketogenesis alters INS signaling and consequently glucose homeostasis (183). Despite it was shown thatĀ Per2Ā controls the hepatic production of ketone bodies (), whether hypothalamic ketogenesis is under the control of the astrocyte clock remains to be investigated. Similarly, whether arrhythmic astrocytes impair glucose homeostasis by contributing to the increased ketogenesis is unknown and could be crucial for therapeutic interventions involving the potentiation of the astrocyte clock.
On the other hand, glucose, as well as glutamine, can be metabolized to uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) through the hexosamine biosynthetic pathway. The reversible enzymatic post-translational modification of proteins (on serine and threonine residues) with UDP-GlcNAc as glucose donor is termed O-GlcNAcylation. This process is conserved across species as occurs both in mouse brains and Drosophila neurons. While in conditions of glucose hypometabolism, brain levels of O-GlcNAc-modified proteins are reduced (188), hyperglycemia increases GlcNAcylation of proteins related to the INS pathway, thus contributing to INS resistance (189). Hyperinsulinemia is also associated with increased GlcNAcylation (189) of proteins involved in the pathology of diabetes, such as glycogen synthase, a major gatekeeper of glucose metabolism (190, 191). On the other hand, O-GlcNAcylation serves as a metabolic sensor to control the circadian period length via modification, and thus changes in the transcriptional activity of CLOCK and PER2 (104). As neurons depend on astroglial glucose and glutamine, this suggests that O-GlcNAcylation of the neuronal clocks might be coupled to astrocyte metabolism. However, further studies are needed to verify this hypothesis.
The metabolic endpoint of glycolysis and the mitochondrial metabolism is ATP generation, which apart from being used to fuel biological reactions is released to the extracellular space (eATP) (eATP) (192). Remarkably, INS stimulates ATP release from astrocytes (193). In turn, eATP leads to rapid upregulation of glycolysis (194) and promotes glucose uptake into both neurons and astrocytes (195). eATP is also a signaling molecule that acts on purinergic, ionotropic P2X, and G-protein coupled P2Y receptors to regulate neuronal activity (196). In the hypothalamus, NPY and AgRP neurons express P2X2R (197), whereas SF-1 neurons are excited by ATP via the P2X4 receptor (198). eATP released by astrocytes can also be metabolized to adenosine. While activation of the A1 receptor by adenosine inhibits appetite-stimulating AgRP neurons (122) (Figure 3), in astrocytes modulate sleep homeostasis (46). Thus, the circadian release of astrocytic ATP (199) and the circadian activity of enzymes involved in adenosine synthesis (200) suggest a central role of the astrocyte clock in modulating both processes. On the other hand, decreased ATP production activates the AMPK pathway to impact the circadian clock via degradation of CRY1 (103). Further investigation will clarify whether astrocytic rhythmic ATP release entrains the neuronal clocks via circadian activation of AMPK to control energy homeostasis and circadian sleep-wake changes in the brain.
Glutamate, the major excitatory neurotransmitter in the adult CNS, is released from neurons and recycled by astrocytes to form glutamine (Figure 3), which is returned to neurons and used as a precursor for synthesizing glutamate and GABA (201). The uptake of glutamate by astrocytes, critical for neuronal activity (202), is metabolically expensive and requires an increase in glycolysis and lactate production (171). Remarkably, control of glutamate and GABA levels, coupled to astrocyte rhythms (40ā43, 203), is necessary for the generation of molecular and behavioral rhythms and, is also critically involved in the modulation of hypothalamic neural circuits controlling glucose homeostasis (39, 204, 205). However, excessive demands on astrocytes, in response to a decrease in glucose levels, impair glutamate uptake (206), altering the glutamatergic signaling to delay the onset of the normal counterregulatory response to hypoglycemia (206). Conversely, intake of an obesogenic diet rapidly increases hypothalamic glutamatergic signaling (207) and the expression of astrocytic glutamate transporters (208). It is reasonable to hypothesize that chronic elevated glutamatergic signaling, associated with diet-induced obesity, increases the metabolic demands on astrocytes to prevent glutamate-induced excitotoxicity. This in turn negatively impacts their ability to support neuronal activity thus, contributing to hypothalamic synaptic dysfunction and the death of POMC neurons (55, 209, 210). Altogether, this suggests that the regulation of glutamate and GABA levels might be a key astrocyte circadian function in normal physiology and likely involved in the alterations of the diabetic brain.
The enteric nervous system is gaining more attention in the last few years. While most of the research focused on the enteric neurons, less attention was directed towards the enteric glial cells (EGCs). Glucose enters the body via the gastrointestinal (GI) tract, and conversely, diabetes-induced GI dysfunction is related to increased apoptosis of EGC in the myenteric plexus (211). On the other hand, the gut clock synchronized by food intake (, 212) regulates the expression of brush border disaccharidases and glucose absorption to the habitual feeding period (168). Moreover, Glucagon-like peptide-1secretion by enteroendocrine L-cells, with an important role in regulating glucose homeostasis (213, 214), is under control of the clock (215). In the gut, also anatomical and metabolome patterns of the microbiota undergo rhythmic fluctuations, resulting in system-wide effects on host circadian transcriptional, epigenetic, and metabolite cycles (216). Interestingly, repeated jet lag in mice disturbs the intestinal microbiome leading to reduced glucose tolerance (216). Similarly, fecal transfer from jet-lagged humans into germ-free mice impaired glucose tolerance (216). These findings suggest that the microbiome clock has an important role in the development of INS resistance due to repeated phase shifts. Altogether, this indicates that the contribution of the gut clock, specifically in the enteric glia, to the control of glucose homeostasis warrants further work.
Altogether, this data indicates that further investigations about the role of the astrocyte clock in maintaining the cycle-to-cycle precision of cellular metabolism and neural rhythmic behavior could be crucial to counteract the systemic metabolic abnormalities associated with circadian disruption.
Circadian Disruption and Diabetes
In this section, we review the current evidence about the contribution of genetic or environmental factors (such as exposure to artificial light-dark cycles, disturbed sleep, shift work, and jet lag) that impact the timekeeping system to the development of insulin resistance and type 2 diabetes.
In humans, mutations in several clock genes are strongly associated with obesity, INS resistance, and type 2 diabetes. Specifically, it was reported associations between single nucleotide polymorphisms inĀ ARNTĀ and T2DMĀ (217), specific haplotypes of CLOCK and obesity (218, 219), and between polymorphisms in CRY2 and elevated fasting glucose (220, 221). In line with the human clock gene mutation studies, rodent models with genetic deletions of core-clock genes (in either a whole-body or a tissue-specific manner) showed INS resistance, obesity, and type 2 diabetes (, 125, 142, 222, 223). Remarkably, deletion of Bmal1 in astrocytes in mice is sufficient to phenocopy the obesity, INS resistance, and glucose intolerance of Bmal1-/- constitutive KO mice (39), suggesting that robust astrocyte circadian rhythms could preserve whole-body homeostasis and metabolic health.
The central pacemaker anticipates and synchronizes the daily function of peripheral tissues according to the entrainment by natural changes in light. With the advent of affordable artificial lighting and the 24/7 lifestyle of our society, humans began to experience increased exposure to artificial lights and irregular light schedules. These environmental changes lead to a desynchronization between the internal clock and the external ZT, a phenomenon referred to as circadian misalignment. Remarkably, human and animal studies have linked obesity and type 2 diabetes with increased light exposure during naturally dark hours (224ā230). In turn, exposure to bright morning light increases fasting and postprandial glucose levels in patients with type 2 diabetes (230). Despite its relevance for health, the molecular and cellular mechanisms of normal and pathological phototransduction in the SCN are unclear. For instance, VIP rhythm, with a key role in synchronizing SCN neurons to each other and with the LD cycle (231, 232), is driven by the LD cycle and not by the circadian clock (233). Thereby, the mechanism by which deletion ofĀ Bmal1Ā in astrocytes constantly elevates VIP levels (40) remains unknown. Indeed, constant illumination increases VIP levels lengthening the circadian period and resulting in two or more peaks in daily activity (234), a circadian locomotor pattern that resembles that of mice with arrhythmic astrocytes (40). Consistently, studies in Drosophila showed that glial-specific genetic manipulations lead to circadian arrhythmicity due to alterations on a clock neuron peptide transmitter (pigment dispersing factor) that acts on a receptor similar to that for VIP in mammals (65, 66). These studies suggest that the astrocyte clock might facilitate the entrainment to light and therefore, to the light-induced phase shifts in physiology and behavior. Further investigations on the mechanism underlying circadian entrainment to light are critical for understanding why aberrant light exposure, disrupts circadian physiology leading to diabetes and INS resistance.
Evidence from epidemiological and experimental studies indicate that sleep restriction or disturbance, increases the risk of obesity and type 2 diabetes (235ā239) likely due to increased food intake (237, 238), altered sympathovagal balance (240, 241), and increased circulating levels of catecholamines (242) or cortisol (241, 242). Interestingly, astrocytes modulate mammalian sleep homeostasis by controlling adenosine A1 receptors (243). The circadian release of the astrocytic transmitter ATP (199) as well as the circadian activity of enzymes involved in the synthesis of adenosine in areas of the brain related to sleep (200) suggests a central role of astrocytes in modulating circadian sleep-wake changes in the brain. Further studies will be needed to understand the importance of astrocyte clocks in the relationship between circadian sleep disorders and diabetes.
Whereas light is the dominant timing cue for the SCN, the time of meals represents the main ZT for peripheral clocks. Therefore is not surprising that extended/erratic eating patterns, such as in shift workers or subjects under experimental circadian misalignment, showed decreased glucose tolerance and insulin sensitivity (244ā250). Indeed, a short-term circadian misalignment protocol of 8 days in humans is sufficient to cause higher blood glucose and insulin levels (249). It is reasonable to hypothesize that disturbance of nutrient fluxes or the misalignment of central and peripheral clock rhythms might contribute to the pathophysiology of insulin resistance at the tissue level. For instance, a mismatch between hepatic glucose production, muscle glucose uptake, and carbohydrate intake could contribute to elevated glucose levels, while an imbalance between lipid storage in WAT, lipid oxidation in BAT, and hepatic lipid production might contribute to ectopic lipid accumulation. However, to improve or prevent the metabolic alterations caused by circadian misalignment we need to further understand the mechanisms involved in the entrainment of both central and peripheral circadian clocks. Remarkably, as astrocytes are at the interface between vessels and neurons, they are in a privileged position to act as metabolic sensors of systemic cues that entrain the peripheral clocks, such as GCs, INS, or IGF1 (, 40, 203). Further studies will clarify whether those metabolic cues might play a crucial role in communicating time-of-feeding to the astrocyte molecular clock linking the periphery and the CNS clocks.
Conclusion
A large body of evidence from human or animal studies demonstrated the circadian regulation of glucose homeostasis and INS sensitivity. However, the exact mechanisms involved in the metabolic derangements resulting from circadian disruption are not fully understood. Emerging groundbreaking findings, showing that astrocytes are pivotal for the circadian regulation of behavior and whole-body energy and glucose homeostasis, could provide a new cellular target to tune physiological responses operating on different timescales according to metabolic status. A key question that remains to be investigated is how the astrocyte clock is entrained to lead to the cycle-to-cycle precision of circadian rhythmicity in the SCN and/or in extra SCN clocks. Therefore, we face a lack of knowledge on the mechanisms by which astrocyte circadian dysfunction affects such a wide range of physiological processes.Ā Understanding these mechanisms will be a challenge for years to come but a crucial aspect in designing better therapies, such as clock agonists, for diabetes. With this knowledge, the use of chronotherapies or temporally directed therapeutics to improve human metabolic healthwill be a matter of time.
Author Contribution
All authors contributed to the article and approved the submitted version. OB-M conceptualized and wrote the manuscript and made the figures. OB-M and ML discussed and edited the manuscript and the figures.
Statements
Acknowledgments
OB-M is supported with a RamĆ³n y Cajal award (RYC2018ā026293āI.) from the Ministerio de Ciencia, InnovaciĆ³n y Universidades of Spain; by Spanish Agencia Estatal de InvestigaciĆ³n (PID2019-109556RB-I00) and the Xunta de Galicia-ConsellerĆa de Cultura, EducaciĆ³n e OrdenaciĆ³n Universitaria (ED431F 2020/009).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
HastingsMHMaywoodESReddyAB. Two decades of circadian time. JĀ Neuroendocrinol (2008) 20:812ā9. doi:Ā 10.1111/j.1365-2826.2008.01715.x
2
MooreRYEichlerVB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res (1972) 42:201ā6. doi:Ā 10.1016/0006-8993(72)90054-6
3
StephanFKZuckerI. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A (1972) 69:1583ā6. doi:Ā 10.1073/pnas.69.6.1583
4
NagoshiESainiCBauerCLarocheTNaefFSchiblerU. Circadian Gene Expression in Individual FibroblastsCell-Autonomous and Self-Sustained Oscillators Pass Time to Daughter Cells. Cell (2004) 119:693ā705. doi:Ā 10.1016/s0092-8674(04)01054-2
5
WelshDKYooSHLiuACTakahashiJSKaySA. Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased circadian rhythms of clock gene expression. Curr Biol (2004) 14:2289ā95. doi:Ā 10.1016/j.cub.2004.11.057
6
PezĆ¼kPMohawkJAWangLAMenakerM. Glucocorticoids as entraining signals for peripheral circadian oscillators. Endocrinology (2012) 153:4775ā83. doi:Ā 10.1210/en.2012-1486
7
CrosbyPHamnettRPutkerMHoyleNPReedMKaramCJet al. Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding Time. Cell (2019) 177:896ā909.e20. doi:Ā 10.1016/j.cell.2019.02.017
8
YanLKaratsoreosILeSauterJWelshDKKaySFoleyDet al. Exploring spatiotemporal organization of SCN circuits. Cold Spring Harbor Symp Quantitative Biol (2007) 72:527ā41. doi:Ā 10.1101/sqb.2007.72.037
9
WenSMaDZhaoMXieLWuQGouLet al. Spatiotemporal single-cell analysis of gene expression in the mouse suprachiasmatic nucleus. Nat Neurosci (2020) 23:456ā67. doi:Ā 10.1038/s41593-020-0586-x
10
SilverRSchwartzWJ. The suprachiasmatic nucleus is a functionally heterogeneous timekeeping organ. Methods Enzymol (2005) 393:451ā65. doi:Ā 10.1016/S0076-6879(05)93022-X
11
WelshDKLogothetisDEMeisterMReppertSM. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron (1995) 14:697ā706. doi:Ā 10.1016/0896-6273(95)90214-7
12
HonmaSNakamuraWShirakawaTHonmaKI. Diversity in the circadian periods of single neurons of the rat suprachiasmatic nucleus depends on nuclear structure and intrinsic period. Neurosci Lett (2004) 358:173ā6. doi:Ā 10.1016/j.neulet.2004.01.022
13
GooleyJJLuJChouTCScammellTESaperCB. Melanopsin in cells of origin of the retinohypothalamic tract. Nat Neurosci (2001) 4:1165. doi:Ā 10.1038/nn768
14
HattarSKumarMParkATongPTungJYauKWet al. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. JĀ Comp Neurol (2006) 497:326ā49. doi:Ā 10.1002/cne.20970
15
GĆ¼lerADEckerJLLallGSHaqSAltimusCMLiaoHWet al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature (2008) 453:102ā5. doi:Ā 10.1038/nature06829
16
BaeKJinXMaywoodESHastingsMHReppertSMWeaverDR. Differential Functions of mPer1, mPer2, and mPer3 in the SCN Circadian Clock al The negative feedback loop involves the dynamic reg. Neuron (2001) 30:525ā36. doi:Ā 10.1016/S0896-6273(01)00302-6
17
DamiolaFLe MinliNPreitnerNKornmannBFleury-OlelaFSchiblerU. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev (2000) 14:2950ā61. doi:Ā 10.1101/gad.183500
18
StokkanKAYamazakiSTeiHSakakiYMenakerM. Entrainment of the circadian clock in the liver by feeding. Sci (80- ) (2001) 291:490ā3. doi:Ā 10.1126/science.291.5503.490
19
HaraRWanKWakamatsuHAidaRMoriyaTAkiyamaMet al. Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes to Cells (2001) 6:269ā78. doi:Ā 10.1046/j.1365-2443.2001.00419.x
20
IzumoMPejchalMSchookACLangeRPWalisserJASatoTRet al. Differential effects of light and feeding on circadian organization of peripheral clocks in a forebrain Bmal1 mutant. Elife (2014) 3:e04617. doi:Ā 10.7554/eLife.04617
21
ShewardWJMaywoodESFrenchKLHornJMHastingsMHSeckJRet al. Entrainment to feeding but not to light: Circadian phenotype of VPAC 2 receptor-null mice. J Neurosci (2007) 27:4351ā8. doi:Ā 10.1523/JNEUROSCI.4843-06.2007
22
FernandezDCKomalRLangelJMaJDuyPQPenzoMAet al. Retinal innervation tunes circuits that drive nonphotic entrainment to food. Nature (2020) 581:194ā8. doi:Ā 10.1038/s41586-020-2204-1
23
DavidsonAJ. Lesion studies targeting food-anticipatory activity. Eur J Neurosci (2009) 30:1658ā64. doi:Ā 10.1111/j.1460-9568.2009.06961.x
24
MistlbergerRE. Neurobiology of food anticipatory circadian rhythms. Physiol Behav (2011) 104:535ā45. doi:Ā 10.1016/j.physbeh.2011.04.015
25
ChalletEMendozaJDardenteHPĆ©vetP. Neurogenetics of food anticipation. Eur J Neurosci (2009) 30:1676ā87. doi:Ā 10.1111/j.1460-9568.2009.06962.x
26
ButlerAAGirardetCMavrikakiMTrevaskisJLMacarthurHMarksDLet al. A life without hunger: The Ups (and downs) to modulating melanocortin-3 receptor signaling. Front Neurosci (2017) 11:128. doi:Ā 10.3389/fnins.2017.00128
27
DavidsonAJCappendijkSLTStephanFK. Feeding-entrained circadian rhythms are attenuated by lesions of the parabrachial region in rats. Am J Physiol - Regul Integr Comp Physiol (2000) 278:R1296ā304. doi:Ā 10.1152/ajpregu.2000.278.5.r1296
28
MendozaJPĆ©vetPFelder-SchmittbuhlMPBaillyYChalletE. The cerebellum harbors a circadian oscillator involved in food anticipation. JĀ Neurosci (2010) 30:1894ā904. doi:Ā 10.1523/JNEUROSCI.5855-09.2010
29
GallardoCMHsuCTGunapalaKMParfyonovMChangCHMistlbergerREet al. Behavioral and neural correlates of acute and scheduled hunger in C57BL/6 mice. PloS One (2014) 9:e95990. doi:Ā 10.1371/journal.pone.0095990
30
ChavanRFeilletCCostaSSFDelormeJEOkabeTRippergerJAet al. Liver-derived ketone bodies are necessary for food anticipation. Nat Commun (2016) 7:10580. doi:Ā 10.1038/ncomms10580
31
DunlapJC. Molecular bases for circadian clocks. Cell (1999) 96:271ā90. doi:Ā 10.1016/S0092-8674(00)80566-8
32
ShiSQAnsariTSMcGuinnessOPWassermanDHJohnsonCH. Circadian disruption leads to insulin resistance and obesity. Curr Biol (2013) 23:372ā81. doi:Ā 10.1016/j.cub.2013.01.048
33
StenversDJScheerFAJLSchrauwenPla FleurSEKalsbeekA. Circadian clocks and insulin resistance. Nat Rev Endocrinol (2019) 15:75ā89. doi:Ā 10.1038/s41574-018-0122-1
34
MarchevaBRamseyKMAffinatiABassJ. Clock genes and metabolic disease. J Appl Physiol (2009) 107:1638ā46. doi:Ā 10.1152/japplphysiol.00698.2009
35
BedrosianTAFonkenLKNelsonRJ. Endocrine Effects of Circadian Disruption. Annu Rev Physiol (2016) 78:109ā31. doi:Ā 10.1146/annurev-physiol-021115-105102
36
Terzibasi-TozziniEMartinez-NicolasALucas-SĆ”nchezA. The clock is ticking. Ageing of the circadian system: From physiology to cell cycle. Semin Cell Dev Biol (2017) 70:164ā76. doi:Ā 10.1016/j.semcdb.2017.06.011
37
UddinMSTewariDMamunAAKabirMTNiazKWahedMIIet al. Circadian and sleep dysfunction in Alzheimerās disease. Ageing Res Rev (2020) 60:101046. doi:Ā 10.1016/j.arr.2020.101046
38
GohVHHTongTYYLeeLKH. Sleep/wake cycle and circadian disturbances in shift work: Strategies for their management - A review. Ann Acad Med Singapore (2000) 29:90ā6.
39
Barca-MayoOBoenderAJArmirottiADe Pietri TonelliD. Deletion of astrocytic BMAL1 results in metabolic imbalance and shorter lifespan in mice. Glia (2020) 68:1131ā47. doi:Ā 10.1002/glia.23764
40
Barca-MayoOPons-EspinalMFollertPArmirottiABerdondiniLDe Pietri TonelliD. Astrocyte deletion of Bmal1 alters daily locomotor activity and cognitive functions via GABA signalling. Nat Commun (2017) 8:14336. doi:Ā 10.1038/ncomms14336
41
TsoCFSimonTGreenlawACPuriTMiedaMHerzogED. Astrocytes Regulate Daily Rhythms in the Suprachiasmatic Nucleus and Behavior. Curr Biol (2017) 27:1055ā61. doi:Ā 10.1016/j.cub.2017.02.037
42
BrancaccioMPattonAPCheshamJEMaywoodESHastingsMH. Astrocytes Control Circadian Timekeeping in the Suprachiasmatic Nucleus via Glutamatergic Signaling. Neuron (2017) 93:1420ā1435.e5. doi:Ā 10.1016/j.neuron.2017.02.030
43
BrancaccioMEdwardsMDPattonAPSmyllieNJCheshamJEMaywoodESet al. Cell-autonomous clock of astrocytes drives circadian behavior in mammals. Sci (80- ) (2019) 363:187ā92. doi:Ā 10.1126/science.aat4104
44
Ben HaimLRowitchDH. Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci (2016) 18:31ā41. doi:Ā 10.1038/nrn.2016.159
45
ZhangYBarresBA. Astrocyte heterogeneity: An underappreciated topic in neurobiology. Curr Opin Neurobiol (2010) 20:588ā94. doi:Ā 10.1016/j.conb.2010.06.005
46
HalassaMMFellinTHaydonPG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med (2007) 3:54ā63. doi:Ā 10.1016/j.molmed.2006.12.005
47
HaberMZhouLMuraiKK. Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J Neurosci (2006) 26:8881ā91. doi:Ā 10.1523/JNEUROSCI.1302-06.2006
48
BushongEAMartoneMEJonesYZEllismanMH. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci (2002) 22:183ā92. doi:Ā 10.1523/jneurosci.22-01-00183.2002
49
SpanagelRPendyalaGAbarcaCZghoulTSanchis-SeguraCMagnoneMCet al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med (2005) 11:35ā42. doi:Ā 10.1038/nm1163
50
BeaulĆ©CSwanstromALeoneMJHerzogED. Circadian modulation of gene expression, but not glutamate uptake, in mouse and rat cortical astrocytes. PloS One (2009) 4:e7476. doi:Ā 10.1371/journal.pone.0007476
51
BlancoMEMayoOBBandieraTTonelliDDPArmirottiA. LCāMS/MS analysis of twelve neurotransmitters and amino acids in mouse cerebrospinal fluid. J Neurosci Methods (2020) 341:108760. doi:Ā 10.1016/j.jneumeth.2020.108760
52
BecquetDGirardetCGuillaumondFFranƧois-BellanAMBoslerO. Ultrastructural plasticity in the rat suprachiasmatic nucleus. Possible involvement in clock entrainment. Glia (2008) 56:294ā305. doi:Ā 10.1002/glia.20613
53
MoniqueLServiĆØreJ. Circadian fluctuations in GFAP distribution in the syrian hamster suprachiasmatic nucleus. Neuroreport (1993) 4:1243ā6. doi:Ā 10.1097/00001756-199309000-00008
54
GirardetCBlanchardMPFerracciGLĆ©vĆŖqueCMorenoMFranƧois-BellanAMet al. Daily changes in synaptic innervation of VIP neurons in the rat suprachiasmatic nucleus: Contribution of glutamatergic afferents. Eur J Neurosci (2010) 31:359ā70. doi:Ā 10.1111/j.1460-9568.2009.07071.x
55
HorvathTLSarmanBGarcĆa-CĆ”ceresCEnrioriPJSotonyiPShanabroughMet al. Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc Natl Acad Sci USA (2010) 107:14875ā80. doi:Ā 10.1073/pnas.1004282107
56
NuzzaciDCansellCLiĆ©nardFNĆ©dĆ©lecEBen FradjSCastelJet al. Postprandial Hyperglycemia Stimulates Neuroglial Plasticity in Hypothalamic POMC Neurons after a Balanced Meal. Cell Rep (2020) 30:3067ā3078.e5. doi:Ā 10.1016/j.celrep.2020.02.029
57
GarcĆa-CĆ”ceresCQuartaCVarelaLGaoYGruberTLegutkoBet al. Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability. Cell (2016) 166:867ā80. doi:Ā 10.1016/j.cell.2016.07.028
58
KimJGSuyamaSKochMJinSArgente-ArizonPArgenteJet al. Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding. Nat Neurosci (2014) 17:908ā10. doi:Ā 10.1038/nn.3725
59
MendelsohnARLarrickJW. Sleep Facilitates Clearance of Metabolites from the Brain: Glymphatic Function in Aging and Neurodegenerative Diseases. Rejuvenation Res (2013) 16:518ā23. doi:Ā 10.1089/rej.2013.1530
60
TaokaTJostGFrenzelTNaganawaSPietschH. Impact of the Glymphatic System on the Kinetic and Distribution of Gadodiamide in the Rat Brain: Observations by Dynamic MRI and Effect of Circadian Rhythm on Tissue Gadolinium Concentrations. Invest Radiol (2018) 53:529ā34. doi:Ā 10.1097/RLI.0000000000000473
61
IliffJJWangMLiaoYPloggBAPengWGundersenGAet al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid Ī². Sci Transl Med (2012) 4:147ra111. doi:Ā 10.1126/scitranslmed.3003748
62
MurlidharanGCrowtherAReardonRASongJAsokanA. Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain. JCI Insight (2016) 1:e88034. doi:Ā 10.1172/jci.insight.88034
63
LeSauterJSilverR. Output signals of the SCN. Chronobiol Int (1998) 15:535ā50. doi:Ā 10.3109/07420529808998706
64
MaywoodESCheshamJEOāBrienJAHastingsMH. A diversity of paracrine signals sustains molecular circadian cycling in suprachiasmatic nucleus circuits. Proc Natl Acad Sci USA. (2011) 108:14306ā11. doi:Ā 10.1073/pnas.1101767108
65
NgFSTangrediMMJacksonFR. Glial cells physiologically modulate clock neurons and circadian behavior in a calcium-dependent manner. Curr Biol (2011) 21:625ā34. doi:Ā 10.1016/j.cub.2011.03.027
66
SuhJJacksonFR. Drosophila Ebony Activity Is Required in Glia for the Circadian Regulation of Locomotor Activity. Neuron (2007) 55:435ā47. doi:Ā 10.1016/j.neuron.2007.06.038
67
JacksonFR. Glial cell modulation of circadian rhythms. Glia (2011) 59:1341ā50. doi:Ā 10.1002/glia.21097
68
WomacADBurkeenJFNeuendorffNEarnestDJZoranMJ. Circadian rhythms of extracellular ATP accumulation in suprachiasmatic nucleus cells and cultured astrocytes. Eur J Neurosci (2009) 30:869ā76. doi:Ā 10.1111/j.1460-9568.2009.06874.x
69
Cornell-BellAHFinkbeinerSMCooperMSSmithSJ. Glutamate induces calcium waves in cultured astrocytes: Long-range glial signaling. Sci (80- ) (1990) 247:470ā3. doi:Ā 10.1126/science.1967852
70
ShinoharaKFunabashiTMitushimaDKimuraF. Effects of gap junction blocker on vasopressin and vasoactive intestinal polypeptide rhythms in the rat suprachiasmatic nucleus in vitro. Neurosci Res (2000) 38:43ā7. doi:Ā 10.1016/S0168-0102(00)00141-3
71
WangMHChenNWangJH. The coupling features of electrical synapses modulate neuronal synchrony in hypothalamic superachiasmatic nucleus. Brain Res (2014) 1550:9ā17. doi:Ā 10.1016/j.brainres.2014.01.007
72
DiemerTLandgrafDNoguchiTPanHMorenoJLWelshDK. Cellular circadian oscillators in the suprachiasmatic nucleus remain coupled in the absence of connexin-36. Neuroscience (2017) 357:1ā11. doi:Ā 10.1016/j.neuroscience.2017.05.037
73
LongMAJutrasMJConnorsBWBurwellRD. Electrical synapses coordinate activity in the suprachiasmatic nucleus. Nat Neurosci (2005) 8:61ā6. doi:Ā 10.1038/nn1361
74
ClasadonteJScemesEWangZBoisonDHaydonPG. Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle. Neuron (2017) 95:1365ā1380.e5. doi:Ā 10.1016/j.neuron.2017.08.022
75
GiantomasiMMalerbaMBarca-MayoOMieleEDe Pietri TonelliDBerdondiniL. A microfluidic device to study molecular clocks synchronization among neuronal populations, in: 41st Annual International Conference of the IEEE Engineering in Medicine. (2019) IEEE. doi:Ā 10.1109/EMBC.2019.8856999
76
CirritoJRDeaneRFaganAMSpinnerMLParsadanianMFinnMBet al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-Ī² deposition in an Alzheimer disease mouse model. J Clin Invest (2005) 115:3285ā90. doi:Ā 10.1172/JCI25247
77
AbbottNJRƶnnbƤckLHanssonE. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 7:41ā53. doi:Ā 10.1038/nrn1824
78
XieLKangHXuQChenMJLiaoYThiyagarajanMet al. Sleep drives metabolite clearance from the adult brain. Sci (80- ) (2013) 342:373ā7. doi:Ā 10.1126/science.1241224
79
NakazatoRKawabeKYamadaDIkenoSMiedaMShimbaSet al. Disruption of Bmal1 impairs blood-brain barrier integrity via pericyte dysfunction. J Neurosci (2017) 37:10052ā62. doi:Ā 10.1523/JNEUROSCI.3639-16.2017
80
ZhangSLYueZArnoldDMArtiushinGSehgalA. A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux. Cell (2018) 173:130ā139.e10. doi:Ā 10.1016/j.cell.2018.02.017
81
Guillod-MaximinELorsignolAAlquierTPĆ©nicaudL. Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: Involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol (2004) 16:464ā71. doi:Ā 10.1111/j.1365-2826.2004.01185.x
82
GaoYLayritzCLegutkoBEichmannTOLaperrousazEMoullĆ©VSet al. Disruption of lipid uptake in astroglia exacerbates diet-induced obesity. Diabetes (2017) 66:2555ā63. doi:Ā 10.2337/db16-1278
83
Le FollCLevinBE. Fatty acid-induced astrocyte ketone production and the control of food intake. Am J Physiol - Regul Integr Comp Physiol (2016) 310:R1186ā92. doi:Ā 10.1152/ajpregu.00113.2016
84
DianoSKalraSPHorvathTL. Leptin receptor immunoreactivity is associated with the Golgi apparatus of hypothalamic neurones and glial cells. J Neuroendocrinol (1998) 10:647ā50. doi:Ā 10.1046/j.1365-2826.1998.00261.x
85
CheunsuangOMorrisR. Astrocytes in the arcuate nucleus and median eminence that take up a fluorescent dye from the circulation express leptin receptors and neuropeptide Y Y1 receptors. Glia (2005) 52:228ā33. doi:Ā 10.1002/glia.20239
86
Cardona-GĆ³mezGPDoncarlosLGarcia-SeguraLM. Insulin-like growth factor I receptors and estrogen receptors colocalize in female rat brain. Neuroscience (2000) 99:751ā60. doi:Ā 10.1016/S0306-4522(00)00228-1
87
DezonneRSLimaFRSTrentinAGGomesFC. Thyroid Hormone and Astroglia: Endocrine Control of the Neural Environment. J Neuroendocrinol (2015) 27:435ā45. doi:Ā 10.1111/jne.12283
88
OāBanionMKYoungDABohnMC. Corticosterone-responsive mRNAs in primary rat astrocytes. Mol Brain Res (1994) 22:57ā68. doi:Ā 10.1016/0169-328X(94)90032-9
89
CarterBSMengFThompsonRC. Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro. Physiol Genomics (2012) 44:1188ā200. doi:Ā 10.1152/physiolgenomics.00097.2012
90
RosenfeldPVan EekelenJAMLevineSDe KloetER. Ontogeny of the Type 2 glucocorticoid receptor in discrete rat brain regions: an immunocytochemical study. Dev Brain Res (1988) 470:119ā27. doi:Ā 10.1016/0165-3806(88)90207-6
91
ZehringWAWheelerDAReddyPKonopkaRJKyriacouCPRosbashMet al. P-element transformation with period locus DNA restores rhythmicity to mutant, arrhythmic drosophila melanogaster. Cell (1984) 39:369ā76. doi:Ā 10.1016/0092-8674(84)90015-1
92
BargielloTAJacksonFRYoungMW. Restoration of circadian behavioural rhythms by gene transfer in Drosophila. Nature (1984) 312:752ā4. doi:Ā 10.1038/312752a0
93
Van Der HorstGTJMuijtjensMKobayashiKTakanoRKannoSITakaoMet al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature (1999) 398:627ā30. doi:Ā 10.1038/19323
94
ZhengBAlbrechtUKaasikKSageMLuWVaishnavSet al. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell (2001) 105:683ā94. doi:Ā 10.1016/S0092-8674(01)00380-4
95
KumeKZylkaMJSriramSShearmanLPWeaverDRJinXet al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell (1999) 98:193ā205. doi:Ā 10.1016/S0092-8674(00)81014-4
96
CoxKHTakahashiJS. Circadian clock genes and the transcriptional architecture of the clock mechanism. J Mol Endocrinol (2019) 63:R93āR102. doi:Ā 10.1530/JME-19-0153
97
PreitnerNDamiolaFLopez-MolinaL-ZakanyJDubouleDAlbrechtUet al. The orphan nuclear receptor REV-ERBĪ± controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell (2002) 110:251ā60. doi:Ā 10.1016/S0092-8674(02)00825-5
98
RichardsJGumzML. Advances in understanding the peripheral circadian clocks. FASEB J (2012) 26:3602ā13. doi:Ā 10.1096/fj.12-203554
99
InokiKKimJGuanKL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol (2012) 52:381ā400. doi:Ā 10.1146/annurev-pharmtox-010611-134537
100
RoblesMSHumphreySJMannM. Phosphorylation Is a Central Mechanism for Circadian Control of Metabolism and Physiology. Cell Metab (2017) 25:118ā27. doi:Ā 10.1016/j.cmet.2016.10.004
101
DangFSunXMaXWuRZhangDChenYet al. Insulin post-transcriptionally modulates Bmal1 protein to affect the hepatic circadian clock. Nat Commun (2016) 7:12696. doi:Ā 10.1038/ncomms12696
102
LucianoAKZhouWSantanaJMKyriakidesCVelazquezHSessaWC. CLOCK phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues. J Biol Chem (2018) 293:9126ā36. doi:Ā 10.1074/jbc.RA117.000773
103
LamiaKASachdevaUMDi TacchioLWilliamsECAlvarezJGEganDFet al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Sci (80- ) (2009) 326:437ā40. doi:Ā 10.1126/science.1172156
104
KaasikKKivimƤeSAllenJJChalkleyRJHuangYBaerKet al. Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab (2013) 17:291ā302. doi:Ā 10.1016/j.cmet.2012.12.017
105
LiMDRuanHBHughesMELeeJSSinghJPJonesSPet al. O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab (2013) 17:303ā10. doi:Ā 10.1016/j.cmet.2012.12.015
106
MaYTLuoHGuanWJZhangHChenCWangZet al. O-GlcNAcylation of BMAL1 regulates circadian rhythms in NIH3T3 fibroblasts. Biochem Biophys Res Commun (2013) 431:382ā7. doi:Ā 10.1016/j.bbrc.2013.01.043
107
NakahataYKaluzovaMGrimaldiBSaharSHirayamaJChenDet al. The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control. Cell (2008) 134:329ā40. doi:Ā 10.1016/j.cell.2008.07.002
108
AsherGGatfieldDStratmannMReinkeHDibnerCKreppelFet al. SIRT1 Regulates Circadian Clock Gene Expression through PER2 Deacetylation. Cell (2008) 134:317ā28. doi:Ā 10.1016/j.cell.2008.06.050
109
FoteinouPTVenkataramanAFranceyLJAnafiRCHogeneschJBDoyleFJ. Computational and experimental insights into the circadian effects of SIRT1. Proc Natl Acad Sci USA (2018) 115:11643ā8. doi:Ā 10.1073/pnas.1803410115
110
AsherGReinkeHAltmeyerMGutierrez-ArcelusMHottigerMOSchiblerU. Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian Clocks to Feeding. Cell (2010) 142:943ā53. doi:Ā 10.1016/j.cell.2010.08.016
111
TakahashiJS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet (2017) 18:164ā79. doi:Ā 10.1038/nrg.2016.150
112
Eckel-MahanKSassone-CorsiP. Metabolism and the circadian clock converge. Physiol Rev (2013) 93:107ā35. doi:Ā 10.1152/physrev.00016.2012
113
SuttonEFBeylREarlyKSCefaluWTRavussinEPetersonCM. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab (2018) 27:1212ā1221.e3. doi:Ā 10.1016/j.cmet.2018.04.010
114
CarrollKFNestelPJ. Diurnal variation in glucose tolerance and in insulin secretion in man. Diabetes (1973) 22:333ā48. doi:Ā 10.2337/diab.22.5.333
115
GibsonTJarrettRJ. Diurnal Variation in Insulin Sensitivity. Lancet (1972) 2:947ā8. doi:Ā 10.1016/S0140-6736(72)92472-5
116
LĆ³pezMTena-SempereM. Estradiol effects on hypothalamic AMPK and BAT thermogenesis: A gateway for obesity treatment? Pharmacol Ther (2017) 178:109ā22. doi:Ā 10.1016/j.pharmthera.2017.03.014
117
TimperKBrĆ¼ningJC. Hypothalamic circuits regulating appetite and energy homeostasis: Pathways to obesity. DMM Dis Model Mech (2017) 10:679ā89. doi:Ā 10.1242/dmm.026609
118
RouthVHHaoLSantiagoAMShengZZhouC. Hypothalamic glucose sensing: Making ends meet. Front Syst Neurosci (2014) 8:236. doi:Ā 10.3389/fnsys.2014.00236
119
WangDHeXZhaoZFengQLinRSunYet al. Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons. Front Neuroanat (2015) 9:40. doi:Ā 10.3389/fnana.2015.00040
120
ShimazuTFukudaABanT. Reciprocal influences of the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content [38]. Nature (1966) 210:1178ā9. doi:Ā 10.1038/2101178a0
121
Fuente-MartĆnEGarciĆ”-CĆ”ceresCArgente-ArizĆ³nPDiĆ”zFGranadoMFreire-RegatilloAet al. Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes. Sci Rep (2016) 6:23673. doi:Ā 10.1038/srep23673
122
YangLQiYYangY. Astrocytes Control Food Intake by Inhibiting AGRP Neuron Activity via Adenosine A1 Receptors. Cell Rep (2015) 11:798ā807. doi:Ā 10.1016/j.celrep.2015.04.002
123
SweeneyPQiYXuZYangY. Activation of hypothalamic astrocytes suppresses feeding without altering emotional states. Glia (2016) 64:2263ā73. doi:Ā 10.1002/glia.23073
124
BassJTakahashiJS. Circadian integration of metabolism and energetics. Sci (80- ) (2010) 330:1349ā54. doi:Ā 10.1126/science.1195027
125
McDearmonELPatelKNKoCHWalisserJASchookACChongJLet al. Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Sci (80- ) (2006) 314:1304ā8. doi:Ā 10.1126/science.1132430
126
Orozco-SolisRAguilar-ArnalLMurakamiMPeruquettiRRamadoriGCoppariRet al. The circadian clock in the ventromedial hypothalamus controls cyclic energy expenditure. Cell Metab (2016) 23:467ā78. doi:Ā 10.1016/j.cmet.2016.02.003
127
CedernaesJHuangWRamseyKMWaldeckNChengLMarchevaBet al. Transcriptional Basis for Rhythmic Control of Hunger and Metabolism within the AgRP Neuron. Cell Metab (2019) 29:1078ā1091.e5. doi:Ā 10.1016/j.cmet.2019.01.023
128
LamiaKAStorchKFWeitzCJ. Physiological significance of a peripheral tissue circadian clock. Proc Natl Acad Sci USA (2008) 105:15172ā7. doi:Ā 10.1073/pnas.0806717105
129
DoiROishiKIshidaN. CLOCK regulates circadian rhythms of hepatic glycogen synthesis through transcriptional activation of Gys2. J Biol Chem (2010) 285:22114ā21. doi:Ā 10.1074/jbc.M110.110361
130
ZhangEELiuYDentinRPongsawakulPYLiuACHirotaTet al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med (2010) 16:1152ā6. doi:Ā 10.1038/nm.2214
131
LamiaKAPappSJYuRTBarishGDUhlenhautNHJonkerJWet al. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature (2011) 480:552ā6. doi:Ā 10.1038/nature10700
132
ToledoMBatista-GonzalezAMerhebEAounMLTarabraEFengDet al. Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1. Cell Metab (2018) 28:268ā81.e4. doi:Ā 10.1016/j.cmet.2018.05.023
133
VollmersCGillSDiTacchioLPulivarthySRLeHDPandaS. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc Natl Acad Sci USA (2009) 106:21453ā8. doi:Ā 10.1073/pnas.0909591106
134
StorchKFLipanOLeykinIViswanathanNDavisFCWongWHet al. Extensive and divergent circadian gene expression in liver and heart. Nature (2002) 417:78ā83. doi:Ā 10.1038/nature744
135
PandaSAntochMPMillerBHSuAISchookABStraumeMet al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell (2002) 109:307ā20. doi:Ā 10.1016/S0092-8674(02)00722-5
136
DeFronzoRATripathyD. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care (2009) Suppl 2:S157ā63. doi:Ā 10.2337/dc09-s302
137
DyarKACiciliotSWrightLEBiensĆøRSTagliazucchiGMPatelVRet al. Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. Mol Metab (2014) 3:29ā41. doi:Ā 10.1016/j.molmet.2013.10.005
138
PerrinLLoizides-MangoldUChanonSGobetCHuloNIseneggerLet al. Transcriptomic analyses reveal rhythmic and CLOCK-driven pathways in human skeletal muscle. Elife (2018) 7:e34114. doi:Ā 10.7554/eLife.34114
139
HongSZhouWFangBLuWLoroEDamleMet al. Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion. Nat Med (2017) 23:223ā34. doi:Ā 10.1038/nm.4245
140
ArasERamadoriGKinouchiKLiuYIorisRMBrenachotXet al. Light Entrains Diurnal Changes in Insulin Sensitivity of Skeletal Muscle via Ventromedial Hypothalamic Neurons. Cell Rep (2019) 27:2385ā98.e3. doi:Ā 10.1016/j.celrep.2019.04.093
141
Carrasco-BensoMPRivero-GutierrezBLopez-MinguezJAnzolaADiez-NogueraAMadridJAet al. Human adipose tissue expresses intrinsic circadian rhythm in insulin sensitivity. FASEB J (2016) 30:3117ā23. doi:Ā 10.1096/fj.201600269RR
142
PaschosGKIbrahimSSongWLKuniedaTGrantGReyesTMet al. Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat Med (2012) 18:1768ā77. doi:Ā 10.1038/nm.2979
143
MinokoshiYHaqueMSShimazuT. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes (1999) 18:1768ā77. doi:Ā 10.2337/diabetes.48.2.287
144
MorganDAMcDanielLNYinTKhanMJiangJAcevedoMRet al. Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus. Diabetes (2015) 64:1976ā87. doi:Ā 10.2337/db14-1257
145
CoutinhoEAOkamotoSIshikawaAWYokotaSWadaNHirabayashiTet al. Activation of SF1 neurons in the ventromedial hypothalamus by DREADD technology increases insulin sensitivity in peripheral tissues. Diabetes (2017) 66:2372ā86. doi:Ā 10.2337/db16-1344
146
Van Der VeenDRShaoJChapmanSLeevyWMDuffieldGE. A diurnal rhythm in glucose uptake in brown adipose tissue revealed by in vivo PET-FDG imaging. Obesity (2012) 20:1527ā9. doi:Ā 10.1038/oby.2012.78
147
van den BergRKooijmanSNoordamRRamkisoensingAAbreu-VieiraGTambyrajahLLet al. A Diurnal Rhythm in Brown Adipose Tissue Causes Rapid Clearance and Combustion of Plasma Lipids at Wakening. Cell Rep (2018) 22:3521ā33. doi:Ā 10.1016/j.celrep.2018.03.004
148
NayakGZhangKXVemarajuSOdakaYBuhrEDHolt-JonesAet al. Adaptive Thermogenesis in Mice Is Enhanced by Opsin 3-Dependent Adipocyte Light Sensing. Cell Rep (2020) 30:672ā86.e8. doi:Ā 10.1016/j.celrep.2019.12.043
149
ZhangKXDāSouzaSUptonBAKernodleSVemarajuSNayakGet al. Violet-light suppression of thermogenesis by opsin 5 hypothalamic neurons. Nature (2020) 585:420ā5. doi:Ā 10.1038/s41586-020-2683-0
150
PerelisMMarchevaBRamseyKMSchipmaMJHutchisonALTaguchiAet al. Pancreatic b cell enhancers regulate rhythmic transcription of genes controlling insulin secretion. Sci (80- ) (2015) 350:aac4250. doi:Ā 10.1126/science.aac4250
151
PeschkeEPeschkeD. Evidence for a circadian rhythm of insulin release from perifused rat pancreatic islets. Diabetologia (1998) 41:1085ā92. doi:Ā 10.1007/s001250051034
152
SadaccaLALamiaKADeLemosASBlumBWeitzCJ. An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. Diabetologia (2011) 54:120ā4. doi:Ā 10.1007/s00125-010-1920-8
153
SainiCPetrenkoVPulimenoPGiovannoniLBerneyTHebrokMet al. A functional circadian clock is required for proper insulin secretion by human pancreatic islet cells. Diabetes Obes Metab (2016) 18:355ā65. doi: 10.1111/dom.12616
154
LeeJKimMSLiRLiuVYFuLMooreDDet al. Loss of Bmal1 leads to uncoupling and impaired glucose-stimulated insulin secretion in Ī²-cells. Islets (2011) 3:381ā8. doi:Ā 10.4161/isl.3.6.18157
155
LaposkyADSheltonJBassJDugovicCPerrinoNTurekFW. Altered sleep regulation in leptin-deficient mice. Am J Physiol - Regul Integr Comp Physiol (2006) 290:R894ā903. doi:Ā 10.1152/ajpregu.00304.2005
156
LaposkyADBradleyMAWilliamsDLBassJTurekFW. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol - Regul Integr Comp Physiol (2008) 295:R2059ā66. doi:Ā 10.1152/ajpregu.00026.2008
157
LesauterJHoqueNWeintraubMPfaffDWSilverR. Stomach ghrelin-secreting cells as food-entrainable circadian clocks. Proc Natl Acad Sci USA (2009) 106:13582ā7. doi:Ā 10.1073/pnas.0906426106
158
BĆ©langerMAllamanIMagistrettiPJ. Brain energy metabolism: Focus on Astrocyte-neuron metabolic cooperation. Cell Metab (2011) 14:724ā38. doi:Ā 10.1016/j.cmet.2011.08.016
159
LeloupCAllardCCarneiroLFioramontiXCollinsSPĆ©nicaudL. Glucose and hypothalamic astrocytes: More than a fueling role? Neuroscience (2016) 323:110ā20. doi:Ā 10.1016/j.neuroscience.2015.06.007
160
ReyGCesbronFRougemontJReinkeHBrunnerMNaefF. Genome-wide and phase-specific DNA-binding rhythms of BMAL1 control circadian output functions in mouse liver. PloS Biol (2011) 9:e1000595. doi:Ā 10.1371/journal.pbio.1000595
161
MorgelloSUsonRRSchwartzEJHaberRS. The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia (1995) 14:43ā54. doi:Ā 10.1002/glia.440140107
162
De los Angeles GarcĆaMMillĆ”nCBalmaceda-AguileraCCastroTPastorPMontecinosHet al. Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem (2003) 86:709ā24. doi:Ā 10.1046/j.1471-4159.2003.01892.x
163
YoungJKMcKenzieJC. GLUT2 immunoreactivity in Gomori-positive astrocytes of the hypothalamus. J Histochem Cytochem (2004) 52:1519ā24. doi:Ā 10.1369/jhc.4A6375.2004
164
OomuraYKimuraKOoyamaHMaenoTMatasaburoIKuniyoshiM. Reciprocal activities of the ventromedial and lateral hypothalamic areas of cats. Sci (80- ) (1964) 143:484ā5. doi:Ā 10.1126/science.143.3605.484
165
MartyNDallaportaMForetzMEmeryMTarussioDBadyIet al. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocytedependent glucose sensors. J Clin Invest (2005) 115:3545ā53. doi:Ā 10.1172/JCI26309
166
BadyIMartyNDallaportaMEmeryMGygerJTarussioDet al. Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes (2006) 55:988ā95. doi:Ā 10.2337/diabetes.55.04.06.db05-1386
167
StolarczykEGuissardCMichauAEvenPCGrosfeldASerradasPet al. Detection of extracellular glucose by GLUT2 contributes to hypothalamic control of food intake. Am J Physiol - Endocrinol Metab (2010) 298:E1078ā87. doi:Ā 10.1152/ajpendo.00737.2009
168
IwashinaIMochizukiKInamochiYGodaT. Clock genes regulate the feeding schedule-dependent diurnal rhythm changes in hexose transporter gene expressions through the binding of BMAL1 to the promoter/enhancer and transcribed regions. J Nutr Biochem (2011) 22:334ā43. doi:Ā 10.1016/j.jnutbio.2010.02.012
169
Å oltĆ©sovĆ”DVeselĆ”AMravecBHerichovĆ”I. Daily profile of glut1 and glut4 expression in tissues inside and outside the blood-brain barrier in control and streptozotocin-treated rats. Physiol Res (2013) 62:S115ā24. doi:Ā 10.33549/physiolres.932596
170
LamTKTGutierrez-JuarezRPocaiARossettiL. Medicine: Regulation of blood glucose by hypothalamic pyruvate metabolism. Sci (80- ) (2005) 309:943ā7. doi:Ā 10.1126/science.1112085
171
MagistrettiPJPellerinL. Cellular Bases of Brain Energy Metabolism and Their Relevance to Functional Brain Imaging: Evidence for a Prominent Role of Astrocytes. Cereb Cortex (1996) 6:50ā61. doi:Ā 10.1093/cercor/6.1.50
172
ParsonsMPHirasawaM. ATP-sensitive potassium channel-mediated lactate effect on orexin neurons: Implications for brain energetics during arousal. J Neurosci (2010) 30:8061ā70. doi:Ā 10.1523/JNEUROSCI.5741-09.2010
173
BurtJAlbertoCOParsonsMPHirasawaM. Local network regulation of orexin neurons in the lateral hypothalamus. Am J Physiol - Regul Integr Comp Physiol (2011) 301:R572ā80. doi:Ā 10.1152/ajpregu.00674.2010
174
LundgaardILuMLYangEPengWMestreHHitomiEet al. Glymphatic clearance controls state-dependent changes in brain lactate concentration. J Cereb Blood Flow Metab (2017) 37:2112ā24. doi:Ā 10.1177/0271678X16661202
175
CespuglioRNetchiporoukLShramN. Glucose and lactate monitoring across the rat sleep-wake cycle. in. Neuromethods (2013) 80:241ā56. doi:Ā 10.1007/978-1-62703-370-1-11
176
RutterJReickMWuLCMcKnightSL. Regulation of crock and NPAS2 DNA binding by the redox state of NAD cofactors. Sci (80- ) (2001) 293:510ā4. doi:Ā 10.1126/science.1060698
177
WiegersECRooijackersHMTackCJHeerschapADe GalanBEVan Der GraafM. Brain lactate concentration falls in response to hypoglycemia in patients with type 1 diabetes and impaired awareness of hypoglycemia. Diabetes (2016) 65:1601ā5. doi:Ā 10.2337/db16-0068
178
De FeyterHMMasonGFShulmanGIRothmanDLPetersenKF. Increased brain lactate concentrations without increased lactate oxidation during hypoglycemia in type 1 diabetic individuals. Diabetes (2013) 62:3075ā80. doi:Ā 10.2337/db13-0313
179
GeisslerAFrĆ¼ndRSchƶlmerichJFeuerbachSZietzB. Alterations of Cerebral Metabolism in Patients with Diabetes Mellitus Studied by Proton Magnetic Resonance Spectroscopy. Exp Clin Endocrinol Diabetes (2003) 111:421ā7. doi:Ā 10.1055/s-2003-44289
180
GeorgeFC. Fuel metabolism in starvation. Annu Rev Nutr (2006) 26:1ā22. doi:Ā 10.1146/annurev.nutr.26.061505.111258
181
Le FollCDunn-MeynellAAMiziorkoHMLevinBE. Regulation of hypothalamic neuronal sensing and food intake by ketone bodies and fatty acids. Diabetes (2014) 63:1259ā69. doi:Ā 10.2337/db13-1090
182
Le FollCDunn-MeynellAAMiziorkoHMLevinBE. Role of VMH ketone bodies in adjusting caloric intake to increased dietary fat content in DIO and DR rats. Am J Physiol - Regul Integr Comp Physiol (2015) 308:R872ā8. doi:Ā 10.1152/ajpregu.00015.2015
183
CarneiroLGellerSHĆ©bertARepondCFioramontiXLeloupCet al. Hypothalamic sensing of ketone bodies after prolonged cerebral exposure leads to metabolic control dysregulation. Sci Rep (2016) 6:34909. doi:Ā 10.1038/srep34909
184
HwangJJJiangLHamzaMSanchez RangelEDaiFBelfort-DeAguiarRet al. Blunted rise in brain glucose levels during hyperglycemia in adults with obesity and T2DM. JCI Insight (2017) 2:e95913. doi:Ā 10.1172/jci.insight.95913
185
KullmannSHeniMHallschmidMFritscheAPreisslHHƤringHU. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev (2016) 96:1169ā209. doi:Ā 10.1152/physrev.00032.2015
186
BakerLDCrossDJMinoshimaSBelongiaDStennis WatsonGCraftS. Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol (2011) 68:51ā7. doi:Ā 10.1001/archneurol.2010.225
187
Weightman PotterPGVlachaki WalkerJMRobbJLChiltonJKWilliamsonRRandallADet al. Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes. Diabetologia (2019) 62:187ā98. doi:Ā 10.1007/s00125-018-4744-6
188
Dos SantosJPAVizueteAHansenFBiasibettiRGonƧalvesCA. Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimerās Disease. J Alzheimerās Dis (2018) 61:237ā49. doi:Ā 10.3233/JAD-170211
189
DiasWBHartGW. O-GlcNAc modification in diabetes and Alzheimerās disease. Mol Biosyst (2007) 3:766ā72. doi:Ā 10.1039/b704905f
190
ParkerGJLundKCTaylorRPMcClainDA. Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine. J Biol Chem (2003) 278:10022ā7. doi:Ā 10.1074/jbc.M207787200
191
ParkerGTaylorRJonesDMcClainD. Hyperglycemia and inhibition of glycogen synthase in streptozotocin-treated mice: Role of O-linked N-acetylglucosamine. J Biol Chem (2004) 279:20636ā42. doi:Ā 10.1074/jbc.M312139200
192
DoschMGerberJJebbawiFBeldiG. Mechanisms of ATP release by inflammatory cells. Int J Mol Sci (2018) 19:1222. doi:Ā 10.3390/ijms19041222
193
CaiWXueCSakaguchiMKonishiMShirazianAFerrisHAet al. Insulin regulates astrocyte gliotransmission and modulates behavior. J Clin Invest (2018) 128:2914ā26. doi:Ā 10.1172/JCI99366
194
JuaristiILlorente-FolchISatrĆŗsteguiJdel ArcoA. Extracellular ATP and glutamate drive pyruvate production and energy demand to regulate mitochondrial respiration in astrocytes. Glia (2019) 67:759ā74. doi:Ā 10.1002/glia.23574
195
LemosCPinheiroBSBelezaROMarquesJMRodriguesRJCunhaRAet al. Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain. Purinergic Signal (2015) 11:561ā9. doi:Ā 10.1007/s11302-015-9474-3
196
JiangLHMousawiFYangXRogerS. ATP-induced Ca2+-signalling mechanisms in the regulation of mesenchymal stem cell migration. Cell Mol Life Sci (2017) 74:3697ā710. doi:Ā 10.1007/s00018-017-2545-6
197
ColldĆ©nGManganoCMeisterB. P2X2 purinoreceptor protein in hypothalamic neurons associated with the regulation of food intake. Neuroscience (2010) 171:62ā78. doi:Ā 10.1016/j.neuroscience.2010.08.036
198
JoYHDonierEMartinezAGarretMToulmĆ©EBouĆ©-GrabotE. Cross-talk between P2X4 and Ī³-aminobutyric acid, type A receptors determines synaptic efficacy at a central synapse. J Biol Chem (2011) 286:19993ā20004. doi:Ā 10.1074/jbc.M111.231324
199
MarpeganLSwanstromAEChungKSimonTHaydonPGKhanSKet al. Circadian regulation of ATP release in astrocytes. J Neurosci (2011) 31:8342ā50. doi:Ā 10.1523/JNEUROSCI.6537-10.2011
200
MackiewiczMNikonovaEVZimmermanJEGalanteRJZhangLCaterJRet al. Enzymes of adenosine metabolism in the brain: Diumal rhythm and the effect of sleep deprivation. J Neurochem (2003) 85:348ā57. doi:Ā 10.1046/j.1471-4159.2003.01687.x
201
VerkhratskyANedergaardM. Physiology of astroglia. Physiol Rev (2018) 98:239ā389. doi:Ā 10.1152/physrev.00042.2016
202
YoungJKBakerJHMontesMI. The brain response to 2-deoxy glucose is blocked by a glial drug. Pharmacol Biochem Behav (2000) 67:233ā9. doi:Ā 10.1016/S0091-3057(00)00315-4
203
Barca MayoOBerdondiniLDe Pietri TonelliD. āAstrocytes and circadian rhythms: An emerging astrocyteāneuron synergy in the timekeeping system,ā in. Methods Mol Biol (2019) 1938:131ā54. doi:Ā 10.1007/978-1-4939-9068-9_10
204
ZhangYReichelJMHanCZuniga-HertzJPCaiD. Astrocytic Process Plasticity and IKKĪ²/NF-ĪŗB in Central Control of Blood Glucose, Blood Pressure, and Body Weight. Cell Metab (2017) 25:1091ā102.e4. doi:Ā 10.1016/j.cmet.2017.04.002
205
ChenNSugiharaHKimJFuZBarakBSurMet al. Direct modulation of GFAP-expressing glia in the arcuate nucleus bi-directionally regulates feeding. Elife (2016) 5:e18716. doi:Ā 10.7554/eLife.18716
206
ChowdhuryGMIWangPCiardiAMamillapalliRJohnsonJZhuWet al. Impaired glutamatergic neurotransmission in the ventromedial hypothalamus may contribute to defective counterregulation in recurrently hypoglycemic rats. in. Diabetes (2017) 66:1979ā89. doi:Ā 10.2337/db16-1589
207
GuyenetSJMatsenMEMortonGJKaiyalaKJSchwartzMW. Rapid glutamate release in the mediobasal hypothalamus accompanies feeding and is exaggerated by an obesogenic food. Mol Metab (2013) 2:116ā22. doi:Ā 10.1016/j.molmet.2013.02.001
208
Fuente-MartiÅEGarcĆa-CĆ”ceresCGranadoMDe CeballosMLSĆ”nchez-GarridoMĆSarmanBet al. Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J Clin Invest (2012) 122:3900ā13. doi:Ā 10.1172/JCI64102
209
ThalerJPYiCXSchurEAGuyenetSJHwangBHDietrichMOet al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2012) 122:153ā62. doi:Ā 10.1172/JCI59660
210
ReisWLYiCXGaoYTschƶpMHSternJE. Brain innate immunity regulates hypothalamic arcuate neuronal activity and feeding behavior. Endocrinology (2015) 156:1303ā15. doi:Ā 10.1210/en.2014-1849
211
ChenYLiuGHeFZhangLYangKYuHet al. MicroRNA 375 modulates hyperglycemia-induced enteric glial cell apoptosis and Diabetes-induced gastrointestinal dysfunction by targeting Pdk1 and repressing PI3K/Akt pathway. Sci Rep (2018) 8:12681. doi:Ā 10.1038/s41598-018-30714-0
212
KonturekPCBrzozowskiTKonturekSJ. Gut clock: Implication of circadian rhythms in the gastointestinal tract. J Physiol Pharmacol (2011) 62:139ā50. doi:Ā 10.2337/db13-1501
213
Gil-LozanoMMingomatajELWuWKRidoutSABrubakerPL. Circadian secretion of the intestinal hormone GLP-1 by the rodent L cell. Diabetes (2014) 63:3674ā85. doi:Ā 10.2337/db13-1501
214
BrubakerPLGil-LozanoM. Glucagon-like peptide-1: The missing link in the metabolic clock? J Diabetes Investig (2016) 7:70ā5. doi:Ā 10.1111/jdi.12477
215
MartchenkoAOhRHWheelerSEGurgesPChalmersJABrubakerPL. Suppression of circadian secretion of glucagon-like peptide-1 by the saturated fatty acid, palmitate. Acta Physiol (2018) 222:e13007. doi:Ā 10.1111/apha.13007
216
ThaissCALevyMKoremTDohnalovĆ”LShapiroHJaitinDAet al. Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations. Cell (2016) 167:1495ā510.e12. doi:Ā 10.1016/j.cell.2016.11.003
217
WoonPYKaisakiPJBraganƧaJBihoreauMTLevyJCFarrallMet al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA (2007) 104:14412ā7. doi:Ā 10.1073/pnas.0703247104
218
ScottEMCarterAMGrantPJ. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (2008) 32:658ā62. doi:Ā 10.1038/sj.ijo.0803778
219
SookoianSGemmaCGianottiTFBurgueƱoACastaƱoGPirolaCJ. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr (2008) 87:1606ā15. doi:Ā 10.1093/ajcn/87.6.1606
220
DupuisJLangenbergCProkopenkoISaxenaRSoranzoNJacksonAUet al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 42:105ā16. doi:Ā 10.1038/ng.520
221
BarkerASharpSJTimpsonNJBouatia-NajiNWarringtonNMKanoniSet al. Association of genetic loci with glucose levels in childhood and adolescence: A meta-analysis of over 6,000 children. Diabetes (2011) 60:1805ā12. doi:Ā 10.2337/db10-1575
222
MarchevaBRamseyKMBuhrEDKobayashiYSuHKoCHet al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature (2010) 466:627ā31. doi:Ā 10.1038/nature09253
223
HogenboomRKalsbeekMJKorpelNLde GoedePKoenenMBuijsRMet al. Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes. Diabetologia (2019) 62:2088ā93. doi:Ā 10.1007/s00125-019-4953-7
224
FonkenLKNelsonRJ. The effects of light at night on circadian clocks and metabolism. Endocr Rev (2014) 35:648ā70. doi:Ā 10.1210/er.2013-1051
225
FonkenLKWorkmanJLWaltonJCWeilZMMorrisJSHaimAet al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA (2010) 107:18664ā9. doi:Ā 10.1073/pnas.1008734107
226
ObayashiKSaekiKIwamotoJIkadaYKurumataniN. Independent associations of exposure to evening light and nocturnal urinary melatonin excretion with diabetes in the elderly. Chronobiol Int (2014) 31:394ā400. doi:Ā 10.3109/07420528.2013.864299
227
ObayashiKSaekiKIwamotoJOkamotoNTomiokaKNezuSet al. Exposure to light at night, nocturnal urinary melatonin excretion, and obesity/dyslipidemia in the elderly: A cross-sectional analysis of the HEIJO-KYO study. J Clin Endocrinol Metab (2013) 98:337ā44. doi:Ā 10.1210/jc.2012-2874
228
McFaddenEJonesMESchoemakerMJAshworthASwerdlowAJ. The relationship between obesity and exposure to light at night: Cross-sectional analyses of over 100,000 women in the breakthrough generations study. Am J Epidemiol (2014) 180:245ā50. doi:Ā 10.1093/aje/kwu117
229
CheungINZeePCShalmanDMalkaniRGKangJReidKJ. Morning and Evening Blue-Enriched Light Exposure Alters Metabolic Function in Normal Weight Adults. PloS One (2016) 11:e0155601. doi:Ā 10.1371/journal.pone.0155601
230
VersteegRIStenversDJVisintainerDLinnenbankATanckMWZwanenburgGet al. Acute Effects of Morning Light on Plasma Glucose and Triglycerides in Healthy Men and Men with Type 2 Diabetes. J Biol Rhythms (2017) 32:130ā42. doi:Ā 10.1177/0748730417693480
231
AtonSJColwellCSHarmarAJWaschekJHerzogED. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci (2005) 8:476ā83. doi:Ā 10.1038/nn1419
232
ColwellCSMichelSItriJRodriguezWTamJLelievreVet al. Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am J Physiol - Regul Integr Comp Physiol (2003) 285:R939ā49. doi:Ā 10.1152/ajpregu.00200.2003
233
TakahashiYOkamuraHYanaiharaNHamadaSFujitaSIbataY. Vasoactive intestinal peptide immunoreactive neurons in the rat suprachiasmatic nucleus demonstrate diurnal variation. Brain Res (1989) 497:374ā7. doi:Ā 10.1016/0006-8993(89)90283-7
234
OhtaHYamazakiSMcMahonDG. Constant light desynchronizes mammalian clock neurons. Nat Neurosci (2005) 8:267ā9. doi:Ā 10.1038/nn1395
235
ShanZMaHXieMYanPGuoYBaoWet al. Sleep duration and risk of type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care (2015) 38:529ā37. doi:Ā 10.2337/dc14-2073
236
CappuccioFPDāEliaLStrazzulloPMillerMA. Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care (2010) 33:414ā20. doi:Ā 10.2337/dc09-1124
237
Bosy-WestphalAHinrichsSJauch-CharaKHitzeBLaterWWilmsBet al. Influence of partial sleep deprivation on energy balance and insulin sensitivity in healthy women. Obes Facts (2008) 1:266ā73. doi:Ā 10.1159/000158874
238
NedeltchevaAVKilkusJMImperialJKaszaKSchoellerDAPenevPD. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr (2009) 89:126ā33. doi:Ā 10.3945/ajcn.2008.26574
239
ReutrakulSMokhlesiB. Obstructive Sleep Apnea and Diabetes: A State of the Art Review. Chest (2017) 152:1070ā86. doi:Ā 10.1016/j.chest.2017.05.009
240
SpiegelKLeproultRVan CauterE. Impact of sleep debt on metabolic and endocrine function. Lancet (1999) 354:1435ā9. doi:Ā 10.1016/S0140-6736(99)01376-8
241
StamatakisKAPunjabiNM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest (2010) 137:95ā101. doi:Ā 10.1378/chest.09-0791
242
RaoMNNeylanTCGrunfeldCMulliganKSchambelanMSchwarzJM. Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab (2015) 100:1664ā71. doi:Ā 10.1210/jc.2014-3911
243
HalassaMMFellinTHaydonPG. Tripartite synapses: Roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology (2009) 57:343ā6. doi:Ā 10.1016/j.neuropharm.2009.06.031
244
VetterCDashtiHSLaneJMAndersonSGSchernhammerESRutterMKet al. Night shift work, genetic risk, and type 2 diabetes in the UK biobank. Diabetes Care (2018) 41:762ā9. doi:Ā 10.2337/dc17-1933
245
GanYYangCTongXSunHCongYYinXet al. Shift work and diabetes mellitus: A meta-analysis of observational studies. Occup Environ Med (2015) 72:72ā8. doi:Ā 10.1136/oemed-2014-102150
246
LeproultRHolmbƤckUVan CauterE. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes (2014) 63:1860ā9. doi:Ā 10.2337/db13-1546
247
QianJDalla ManCMorrisCJCobelliCScheerFAJL. Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans. Diabetes Obes Metab (2018) 20:2481ā5. doi:Ā 10.1111/dom.13391
248
WefersJVan MoorselDHansenJConnellNJHavekesBHoeksJet al. Circadian misalignment induces fatty acid metabolism gene profiles and compromises insulin sensitivity in human skeletal muscle. Proc Natl Acad Sci USA (2018) 115:7789ā94. doi:Ā 10.1073/pnas.1722295115
249
ScheerFAJLHiltonMFMantzorosCSSheaSA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA (2009) 106:4453ā8. doi:Ā 10.1073/pnas.0808180106
250
MorrisCJPurvisTEMistrettaJScheerFAJL. Effects of the internal circadian system and circadian misalignment on glucose tolerance in chronic shift workers. J Clin Endocrinol Metab (2016) 101:1066ā74. doi:Ā 10.1210/jc.2015-3924
Summary
Keywords
astrocytes, circadian clock, metabolism, diabetes, glucose homeostasis
Citation
Barca-Mayo O and LĆ³pez M (2021) Astrocyte Clocks and Glucose Homeostasis. Front. Endocrinol. 12:662017. doi: 10.3389/fendo.2021.662017
Received
31 January 2021
Accepted
01 March 2021
Published
18 March 2021
Volume
12 - 2021
Edited by
Cristina GarcĆa CĆ”ceres, Ludwig Maximilian University of Munich, Germany
Reviewed by
Alexandre Benani, Centre National de la Recherche Scientifique (CNRS), France; Paulo Kofuji, University of Minnesota Twin Cities, United States
Updates
Copyright
Ā© 2021 Barca-Mayo and LĆ³pez.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Olga Barca-Mayo, olga.barca.mayo@usc.es
This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.